1 Min Read
Oct 26 (Reuters) - Prometic Life Sciences Inc
* Prometic receives clearance from the Swedish Medical Products Agency to initiate Plasminogen diabetic foot ulcer mid-stage clinical trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.